Australia | May 29 2006
By Rudi Filapek-Vandyck
All is not well at Nylex (NLX) and the investment community is taking notice. Last week we reported how analysts at Smith Barney Citigroup had decided to stop covering the company (but not before they made a final downgrade to Sell and slashed their price target to $0.04).
This week their colleagues at Credit Suisse have come to similar conclusions: Underperform and a price target of $0.045. Nylex shareholders trying to seek a positive angle in the fact that Credit Suisse’s price target is $0.005 above Citigroup’s and that the broker hasn’t hung up on the company yet better face the harsh reality: Nylex’s future is as uncertain as can be.
Credit Suisse analysts bluntly state they are unable to form an educated opinion on the valuation of the company and have therefore requested a meeting with the company’s management.
In case this meeting cannot take place, they intend to stop covering the company.

